chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: HEP
Symptoms: Parechovirus infection, Poor feeding infant, Respiratory failure, Septic shock, Viral test positive
Clinical narrative: lethargy, hypoglycemia, decreased feeding, which progressed to brain injury, septic shock and respiratory failure requiring intubation and encephalomalacia. was + parechovirus, but negative bacterial work-up or metabolic, genetic work-up for cause. Still suffering from insult to brain with developmental delay, difficulty feeding, abnormal MRIs.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/22/2023 ABDOMINAL PAIN
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: cervical lymphadenopathy -45mm diameter(i.e. size of a golf ball)
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Abnormal behaviour, Dyskinesia, Dyspnoea, Glassy eyes, Laboratory test normal
Clinical narrative: Charge nurse note: @ 2120, LNA reported resident "wasn't right", stated resident was noted to be "flailing his arms". Upon entry into the room resident was found to be unresponsive to sternal rub, labored breathing with RR of 28, blood trickling from the corner of his mouth. Initial VS: 97.9, 112, 28, 240/80, 97% RA. 2 L of O2 was applied as supportive measure. No convulsions noted with this RN's assessment. Supervisor called to floor. Resident a full code--EMS was activated. Within 5 minutes resident's RR came down to 20, nonlabored, making eye contact when his name is called. F/u b/p 180/80. Upon EMS arrival resident was speaking in short sentences when questioned. Resident out to ED @ 2140. Nurse to nurse report given to RN at ED. Nsg. Supervisor note: Called by charge nurse to see resident, LNA reported she heard resident thrashing loudly and that she thought there was someone else in the room with the resident. She stated he was "flailing his arms up here" as she demonstrated what she had observed. Upon entry into the room resident was found to be unresponsive, glazed stare, no response to verbal prompts, labored respirations of 24 on oxygen via face mask, LNA states blood came out of his mouth, repositioned on left side. Resident is a full code and EMS was activated. Upon EMS arrival resident more responsive and responded "hi" with no further further flailing noted. NP notified and resident out to ED @ 2140 with paperwork provided to the EMS staff.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Mouth haemorrhage, Staring, Troponin increased, Unresponsive to stimuli
Clinical narrative: Charge nurse note: @ 2120, LNA reported resident "wasn't right", stated resident was noted to be "flailing his arms". Upon entry into the room resident was found to be unresponsive to sternal rub, labored breathing with RR of 28, blood trickling from the corner of his mouth. Initial VS: 97.9, 112, 28, 240/80, 97% RA. 2 L of O2 was applied as supportive measure. No convulsions noted with this RN's assessment. Supervisor called to floor. Resident a full code--EMS was activated. Within 5 minutes resident's RR came down to 20, nonlabored, making eye contact when his name is called. F/u b/p 180/80. Upon EMS arrival resident was speaking in short sentences when questioned. Resident out to ED @ 2140. Nurse to nurse report given to RN at ED. Nsg. Supervisor note: Called by charge nurse to see resident, LNA reported she heard resident thrashing loudly and that she thought there was someone else in the room with the resident. She stated he was "flailing his arms up here" as she demonstrated what she had observed. Upon entry into the room resident was found to be unresponsive, glazed stare, no response to verbal prompts, labored respirations of 24 on oxygen via face mask, LNA states blood came out of his mouth, repositioned on left side. Resident is a full code and EMS was activated. Upon EMS arrival resident more responsive and responded "hi" with no further further flailing noted. NP notified and resident out to ED @ 2140 with paperwork provided to the EMS staff.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: patient present back to the pharmacy with left arm red, warm to the touch, and swollen. patient advised to take an allergy medicine to help with symptoms.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: Adenovirus test, Body temperature increased, Culture urine, Febrile convulsion, Human metapneumovirus test
Clinical narrative: Child experienced a  febrile seizure on 6/2/2023 and was transported by ambulance to ER  Seizure lasted from 2- 5 minutes  Seemed gray  Shaking  T max 100.8 Parients mother concerned this may be a reaction to the vaccines she received on 5/25/2023
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: Human rhinovirus test, Influenza virus test, Microscopy, Pallor, Respirovirus test
Clinical narrative: Child experienced a  febrile seizure on 6/2/2023 and was transported by ambulance to ER  Seizure lasted from 2- 5 minutes  Seemed gray  Shaking  T max 100.8 Parients mother concerned this may be a reaction to the vaccines she received on 5/25/2023
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: Rubulavirus test, Tremor, Urine analysis, Viral test
Clinical narrative: Child experienced a  febrile seizure on 6/2/2023 and was transported by ambulance to ER  Seizure lasted from 2- 5 minutes  Seemed gray  Shaking  T max 100.8 Parients mother concerned this may be a reaction to the vaccines she received on 5/25/2023
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Wrong product administered
Clinical narrative: PATIENT PRESENTED TO THE OFFICE FOR 2ND HEPLISAV DOSE ON 06/06/23. AT 10:46, PROVIDER RECEIVED AN TEXT FROM MEDICAL ASSISTANT FOR ENGERIX-B ORDER. PROVIDER PLACED THE ORDER TO HEPLISAV-B GIVEN HER 1ST DOSE WAS HEPLISAV. PROVIDER WAS ASKED BY MEDICAL ASSISTANT TO CHANGE THE ORDER TO OTHER HEP B. MEDICAL ASSISTANT WAS INFORMED THAT PATIENT RECEIVED HEPLISAV AS FIRST DOSE OF PATIENT'S SERIES. PATIENT SHOULD GET HEPLISAVE AS HER SECOND DOSE. PROVIDER WAS INFORMED BY MEDICAL ASSISTANT THAT ENGERIX-B WAS GIVEN TO PATIENT. PROVIDER HAS NOT SEEN PATIENT AT THIS TIME. SPOKE WITH CRNP DNP. PATIENT WILL NEED TO RETURN TO OFFICE FOR SECOND HEPLISAV-B VACCINE IN 6 MONTHS. PATIENT WAS INFORMED BY MEDICAL ASSISTANT THAT PATIENT RECEIVED ENGERIX AND PATIENT WILL NEED TO RETURN TO OFFICE IN 6 MONTHS TO GET SECOND HEPLISAV INJECTION. PROVIDER TRIED TO REACH OUT TO PATIENT FOR FOLLOW-UP ON 06/07/23 VIA THE PHONE. NO ANSWER.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE ACUTE HYPERCAPNIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA 11/28/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE ACUTE HYPERCAPNIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA 11/28/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: PULMONARY EMBOLISM, UNSPECIFIED.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Oesophageal carcinoma
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/5/2023 ESOPHAGEAL CANCER, UNSPECIFIED SITE ACUTE RESPIRATORY FAILURE 4/5/2023 ADVANCE DIRECTIVE DISCUSSED W PATIENT
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Myocardial ischaemia, Pulmonary embolism
Clinical narrative: DEMAND ISCHEMIA ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE PULMONARY EMBOLISM 11/7/2022 - RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Was administered a vaccine past the BUD date
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Headache, Lipoma, Lymphadenopathy, Mass
Clinical narrative: DEVELOPED URTICARIA- HEADACHES- SWOLLEN LYMPH NODES UPPER LEFT SIDE OF CHEST AND RIGHT SIDE GROIN AREA.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: DEVELOPED URTICARIA- HEADACHES- SWOLLEN LYMPH NODES UPPER LEFT SIDE OF CHEST AND RIGHT SIDE GROIN AREA.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Coagulopathy
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE
Age: 17.0
Sex: F
Vaccine: HPV9
Symptoms: Erythema, Mobility decreased, Pain in extremity
Clinical narrative: PAIN AND REDNESS TO ARM UNABLE TO PICK UP ARM
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC RESPIRATORY FAILURE
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Administered an expired vaccine to a patient. The vial had been moved to the refrigerator 71 days ago, and was incorrectly labeled.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Administered an expired vaccine to a patient. Vaccine had been moved to the fridge 71 days ago and was incorrectly labeled.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: No adverse event, Product preparation error
Clinical narrative: no adverse event.  Patient was only given the diluent part of the Pentacel vaccine.  The diluent was never mixed with the powder vial.  Nothing happened to baby.  When doing inventory, I caught mistake and notified provider as well as the patient's mother and she is bringing patient back in on 6/8/2023 for repeat Pentacel Vaccination.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Patient was administered a dose of the monovalent COVID-19 vaccines after they were no longer authorized. Patient was notified and reported she had no symptoms.
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Vomiting
Clinical narrative: Patient was taken to ER with symptoms of vomiting. Mother states patient was given Zofran in ER and has not thrown up since. Mother states patient is doing better this morning.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: Numbness to face, head, legs, feet, left arm
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Pulmonary embolism, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM 12/11/2022 &  2/14/2023 --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site inflammation, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Within 12 hrs, right arm became inflamed and puffy from injection site at right deltoid to elbow.  Patient mentioned feelings of hotness and itchiness all in reaction site.  within 12 hrs of injection of vaccine, reaction appeared, and 144 hrs/6 days after initial injection, arm began the process of returning to typical state.
Age: 73.0
Sex: M
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: None.  Patient was supposed to get a Pneumovax vaccination and received a Menveo vaccination instead.  I caught this when I was doing inventory and notified the provider.  The provider asked for me to call and explain to the patient what happened and see if he would return to the clinic to get the correct immunization Pneumovax.  I called and left a message for the patient to return my call.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness
Clinical narrative: dizziness
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Decreased appetite
Clinical narrative: On 5/23/2023, I felt a little run-down. I developed nasal congestion and the beginning of a sore throat. On 5/24/2023, each of the symptoms got worse. On that day, I took TYLENOL, which helped. That evening, I developed a fever. The TYLENOL helped reduce it, but as soon as the TYLENOL wore off after about six hours, the temperature would spike again. On 5/25/2023, I took a home antigen test in the morning and got a positive result. I began resting, and my fatigue, nasal congestion, chest congestion, cough, and sneezing got worse. I also ran a fever of about 101. I continued to take TYLENOL that day, and it continued to help my symptoms. I also lost my senses of taste and smell. I emailed my doctor for guidance, and he advised me to continue taking TYLENOL and resting. He also told me to hold off on taking PAXLOVID. On 5/26/2023, the symptoms continued, though the chest congestion got worse. On 5/27/2023, I had profound fatigue. I took a nap in the early afternoon, and within about an hour, I woke up with a wet cough. It produced a lot of phlegm. I had some trouble breathing, so I immediately sent another email to my doctor. My doctor then advised me to start the PAXLOVID regimen immediately. I was on PAXLOVID for five days afterwards. Within the first 24 hours of beginning the PAXLOVID, my symptoms began to improve. I still had all the symptoms, but they were now less intense. My main issue was then the fatigue, because it continued in its intensity. Within 12 hours of starting the PAXLOVID, I had profound side effects that included persistent diarrhea, headache, and loss of appetite. The side effects continued for the next four days that I took the medication. On about 6/1/2023, I took another home antigen test and got a negative result. At this point, my symptoms were similar to those of a mild cold and included nasal congestion, minor sore throat, and continuing loss of appetite. I continued to isolate and rest during this time. I felt better, but I still had profound fatigue. On 6/4/2023, I took another home antigen test and got a positive result; I had a rebound. On the evening of 6/5/2023, I took another test and got a negative result. I took a test this morning, and the result was still negative. At the time of this writing, I continue to experience fatigue and diminished smell and taste, but I feel better than I did earlier during my illness.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Nasal congestion
Clinical narrative: On 5/23/2023, I felt a little run-down. I developed nasal congestion and the beginning of a sore throat. On 5/24/2023, each of the symptoms got worse. On that day, I took TYLENOL, which helped. That evening, I developed a fever. The TYLENOL helped reduce it, but as soon as the TYLENOL wore off after about six hours, the temperature would spike again. On 5/25/2023, I took a home antigen test in the morning and got a positive result. I began resting, and my fatigue, nasal congestion, chest congestion, cough, and sneezing got worse. I also ran a fever of about 101. I continued to take TYLENOL that day, and it continued to help my symptoms. I also lost my senses of taste and smell. I emailed my doctor for guidance, and he advised me to continue taking TYLENOL and resting. He also told me to hold off on taking PAXLOVID. On 5/26/2023, the symptoms continued, though the chest congestion got worse. On 5/27/2023, I had profound fatigue. I took a nap in the early afternoon, and within about an hour, I woke up with a wet cough. It produced a lot of phlegm. I had some trouble breathing, so I immediately sent another email to my doctor. My doctor then advised me to start the PAXLOVID regimen immediately. I was on PAXLOVID for five days afterwards. Within the first 24 hours of beginning the PAXLOVID, my symptoms began to improve. I still had all the symptoms, but they were now less intense. My main issue was then the fatigue, because it continued in its intensity. Within 12 hours of starting the PAXLOVID, I had profound side effects that included persistent diarrhea, headache, and loss of appetite. The side effects continued for the next four days that I took the medication. On about 6/1/2023, I took another home antigen test and got a negative result. At this point, my symptoms were similar to those of a mild cold and included nasal congestion, minor sore throat, and continuing loss of appetite. I continued to isolate and rest during this time. I felt better, but I still had profound fatigue. On 6/4/2023, I took another home antigen test and got a positive result; I had a rebound. On the evening of 6/5/2023, I took another test and got a negative result. I took a test this morning, and the result was still negative. At the time of this writing, I continue to experience fatigue and diminished smell and taste, but I feel better than I did earlier during my illness.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Oropharyngeal pain, Productive cough, Pyrexia, Respiratory tract congestion
Clinical narrative: On 5/23/2023, I felt a little run-down. I developed nasal congestion and the beginning of a sore throat. On 5/24/2023, each of the symptoms got worse. On that day, I took TYLENOL, which helped. That evening, I developed a fever. The TYLENOL helped reduce it, but as soon as the TYLENOL wore off after about six hours, the temperature would spike again. On 5/25/2023, I took a home antigen test in the morning and got a positive result. I began resting, and my fatigue, nasal congestion, chest congestion, cough, and sneezing got worse. I also ran a fever of about 101. I continued to take TYLENOL that day, and it continued to help my symptoms. I also lost my senses of taste and smell. I emailed my doctor for guidance, and he advised me to continue taking TYLENOL and resting. He also told me to hold off on taking PAXLOVID. On 5/26/2023, the symptoms continued, though the chest congestion got worse. On 5/27/2023, I had profound fatigue. I took a nap in the early afternoon, and within about an hour, I woke up with a wet cough. It produced a lot of phlegm. I had some trouble breathing, so I immediately sent another email to my doctor. My doctor then advised me to start the PAXLOVID regimen immediately. I was on PAXLOVID for five days afterwards. Within the first 24 hours of beginning the PAXLOVID, my symptoms began to improve. I still had all the symptoms, but they were now less intense. My main issue was then the fatigue, because it continued in its intensity. Within 12 hours of starting the PAXLOVID, I had profound side effects that included persistent diarrhea, headache, and loss of appetite. The side effects continued for the next four days that I took the medication. On about 6/1/2023, I took another home antigen test and got a negative result. At this point, my symptoms were similar to those of a mild cold and included nasal congestion, minor sore throat, and continuing loss of appetite. I continued to isolate and rest during this time. I felt better, but I still had profound fatigue. On 6/4/2023, I took another home antigen test and got a positive result; I had a rebound. On the evening of 6/5/2023, I took another test and got a negative result. I took a test this morning, and the result was still negative. At the time of this writing, I continue to experience fatigue and diminished smell and taste, but I feel better than I did earlier during my illness.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: On 5/23/2023, I felt a little run-down. I developed nasal congestion and the beginning of a sore throat. On 5/24/2023, each of the symptoms got worse. On that day, I took TYLENOL, which helped. That evening, I developed a fever. The TYLENOL helped reduce it, but as soon as the TYLENOL wore off after about six hours, the temperature would spike again. On 5/25/2023, I took a home antigen test in the morning and got a positive result. I began resting, and my fatigue, nasal congestion, chest congestion, cough, and sneezing got worse. I also ran a fever of about 101. I continued to take TYLENOL that day, and it continued to help my symptoms. I also lost my senses of taste and smell. I emailed my doctor for guidance, and he advised me to continue taking TYLENOL and resting. He also told me to hold off on taking PAXLOVID. On 5/26/2023, the symptoms continued, though the chest congestion got worse. On 5/27/2023, I had profound fatigue. I took a nap in the early afternoon, and within about an hour, I woke up with a wet cough. It produced a lot of phlegm. I had some trouble breathing, so I immediately sent another email to my doctor. My doctor then advised me to start the PAXLOVID regimen immediately. I was on PAXLOVID for five days afterwards. Within the first 24 hours of beginning the PAXLOVID, my symptoms began to improve. I still had all the symptoms, but they were now less intense. My main issue was then the fatigue, because it continued in its intensity. Within 12 hours of starting the PAXLOVID, I had profound side effects that included persistent diarrhea, headache, and loss of appetite. The side effects continued for the next four days that I took the medication. On about 6/1/2023, I took another home antigen test and got a negative result. At this point, my symptoms were similar to those of a mild cold and included nasal congestion, minor sore throat, and continuing loss of appetite. I continued to isolate and rest during this time. I felt better, but I still had profound fatigue. On 6/4/2023, I took another home antigen test and got a positive result; I had a rebound. On the evening of 6/5/2023, I took another test and got a negative result. I took a test this morning, and the result was still negative. At the time of this writing, I continue to experience fatigue and diminished smell and taste, but I feel better than I did earlier during my illness.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous, Tenderness
Clinical narrative: Tender red rash to arm
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aphasia, Blindness, Condition aggravated, Fatigue, Migraine
Clinical narrative: I have a lifelong affliction with migraine, with aura. I only get them 1-2 times a year, and they follow the classic migraine pattern. I got a rare one the week after my second Pfizer bivalent booster which was offered to autoimmune patients. Migraine had 24 hours of feeling groggy, a half hour vision loss aura, and a half hour speech aphasia, followed by left sided moderate brain pain over the next 36 hours.   It was not severe, I have had much worse ones from cleaning chemicals or foods. It was unusual in the timing and seemed to have been vaccine triggered. I was also in a significant amount of muscle pain and fatigue with this booster the week following.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Migraine with aura, Myalgia, Somnolence
Clinical narrative: I have a lifelong affliction with migraine, with aura. I only get them 1-2 times a year, and they follow the classic migraine pattern. I got a rare one the week after my second Pfizer bivalent booster which was offered to autoimmune patients. Migraine had 24 hours of feeling groggy, a half hour vision loss aura, and a half hour speech aphasia, followed by left sided moderate brain pain over the next 36 hours.   It was not severe, I have had much worse ones from cleaning chemicals or foods. It was unusual in the timing and seemed to have been vaccine triggered. I was also in a significant amount of muscle pain and fatigue with this booster the week following.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 15.0
Sex: F
Vaccine: HPV9, MMR, VARCEL
Symptoms: Extra dose administered, Product administration error
Clinical narrative: Pt had already received 2 MMR vaccines and was given a third when it was not needed/ordered. Error reported by CMA to provider. Provider indicated that there would be no adverse concerns for patient.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Electrocardiogram normal, Hepatic cirrhosis, Hepatic enzyme increased, Ultrasound liver abnormal
Clinical narrative: I had blood work done in March 2023 and in April I saw the doctor because I was planning to have a knee replacement.  In one month's, time my liver enzymes had jumped from about 67 to 676.  I was sent for an ultrasound of the liver and they found cirrosis of the liver, non-alcoholic.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Loss of consciousness
Clinical narrative: Pt stood up and blacked out
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Redness and itching to the injection site 10 minutes after injection.  Treatment included bandaid removal and oral Benadryl 50 mg.  Itching resolved with the removal of the bandaid.  Patient was observed for 30 minutes with no further symptoms.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 12/3/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: arm at site of injection - red, warm to the touch and tender.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Interstitial lung disease
Clinical narrative: R09.02 HYPOXEMIA 2/28/2023 INTERSTITIAL LUNG DISEASE
Age: 26.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain upper, Back pain, Headache, Impaired work ability, Nausea
Clinical narrative: Patient received vaccine at approximately 6:30 pm on 06-06-2023. She woke up at approximately 2:30 am on 06-07-2023 with  stomach pain, nausea, and headache. She also complains of back pain so severe that she had to leave work.
Age: 100.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Upper gastrointestinal haemorrhage
Clinical narrative: I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/20/2023 UPPER GI HEMORRHAGE
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Deep vein thrombosis, Pulmonary embolism
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE ACUTE DVT, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic kidney disease, Glomerular filtration rate, Hypotension
Clinical narrative: HYPOTENSION 2/22/2023 CKD STAGE 3B (GFR 30-44)
Age: 79.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pt. said 4 days after receiveing vaccine injection site was red, swollen, and sore. It was not the days after vaccine.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: I did not have an adverse reaction to the vaccine. In 2020, I had COVID-19 and since then my allergies and tinnitus have been worse. My allergies are worse each year from February to May.  I have tinnitus in both, and the left is worse. I take allergy shots regularly.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY HYPOTENSION
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, COVID-19, Hypoglycaemia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "71-year-old married female with past medical history significant for morbid obesity with significant intentional weight loss, type 2 diabetes mellitus, hypertension, hyperlipidemia, obstructive sleep apnea with poor compliance with CPAP, breast cancer in 2005 with no known recurrence, nonalcoholic fatty liver disease and gout presented with several-day history of word-finding difficulty consistent with expressive aphasia.  There was also some question of her being confused on presentation.  She reportedly had transient episodes of hypoglycemia at home and was positive for COVID-19 on admission without any fevers, respiratory or GI symptoms."
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Discomfort, Headache, Medical procedure, Pain, Stress
Clinical narrative: After reaching out to confirm date to schedule second dose, patient explained that Shingrix had triggered / caused a severe episode of trigeminal neuralgia. Patient stated that he had been hospitalized for an extended period of time with multiple procedures with extreme pain and discomfort. Patient advised that he is now taking new medication to help treat his condition and only now is starting to feel some relief. Symptoms included severe headache, pain, discomfort, stress.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Trigeminal neuralgia
Clinical narrative: After reaching out to confirm date to schedule second dose, patient explained that Shingrix had triggered / caused a severe episode of trigeminal neuralgia. Patient stated that he had been hospitalized for an extended period of time with multiple procedures with extreme pain and discomfort. Patient advised that he is now taking new medication to help treat his condition and only now is starting to feel some relief. Symptoms included severe headache, pain, discomfort, stress.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Contusion
Clinical narrative: I had bruising all over my body
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Anaphylactic reaction, Cough, Rash, Urticaria, Vomiting
Clinical narrative: 6/6/2023 1628- Pt arrived to facility for scheduled nurse visit to receive MMRV and Dtap/IPV vaccinations. 1636- Patient and mother check out at front desk 1645- Patient was left facility, when leaving he started to cough and spit-up; Mother was driving, immediately after leaving the office, he started to have worsening of his cough, spitting up. Mother noticed rash starting all over.   1654- Mother brought patient back to facility 1655- MD Provider was called since she was still in parking lot, provider came back to see the patient who was having anaphylactic reaction.   1656 -1700- vital signs taken- HR 127, RR 29, SPo2 92%; Provider assessed patient: he was wheezing, coughing, spitting up and diffuse urticaria. 1705-1710: Decadron 2mL given L thigh IM 1715-1720: Epi 0.2mL given R thigh IM 1725-1730: Xopenex neb treatment given; Vital signs taken: SpO2:99%, RR 25-33, HR 119-121  1735-1740: Benadryl PO given 1735-1740: Motrin PO given 1740-1755- Provider determined patient was in stable condition 1756- Patient checked out of office and left facility with mother  6/7/2023 0930- Patient was seen in office for follow up visit with NP. Patient was referred to allergist for further follow up for anaphylaxis.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Wheezing
Clinical narrative: 6/6/2023 1628- Pt arrived to facility for scheduled nurse visit to receive MMRV and Dtap/IPV vaccinations. 1636- Patient and mother check out at front desk 1645- Patient was left facility, when leaving he started to cough and spit-up; Mother was driving, immediately after leaving the office, he started to have worsening of his cough, spitting up. Mother noticed rash starting all over.   1654- Mother brought patient back to facility 1655- MD Provider was called since she was still in parking lot, provider came back to see the patient who was having anaphylactic reaction.   1656 -1700- vital signs taken- HR 127, RR 29, SPo2 92%; Provider assessed patient: he was wheezing, coughing, spitting up and diffuse urticaria. 1705-1710: Decadron 2mL given L thigh IM 1715-1720: Epi 0.2mL given R thigh IM 1725-1730: Xopenex neb treatment given; Vital signs taken: SpO2:99%, RR 25-33, HR 119-121  1735-1740: Benadryl PO given 1735-1740: Motrin PO given 1740-1755- Provider determined patient was in stable condition 1756- Patient checked out of office and left facility with mother  6/7/2023 0930- Patient was seen in office for follow up visit with NP. Patient was referred to allergist for further follow up for anaphylaxis.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Deep vein thrombosis, Hypotension, Hypoxia, Pulmonary embolism
Clinical narrative: ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS HYPOTENSION ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS HYPOTENSION ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE MI 12/25/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Brain fog, Fatigue, Lethargy
Clinical narrative: PER PATIENT HE HAS BEEN EXPERIENCING FATIGUE, LETHARGY AND BRAIN FOG STARTING 1-2 DAYS AFTER RECEIVING THE VACCINE
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: ANGINA, UNSPECIFIED
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
Age: 41.0
Sex: F
Vaccine: RAB
Symptoms: Anti-ganglioside antibody positive, Blood test abnormal, Burning sensation, Chronic inflammatory demyelinating polyradiculoneuropathy, Electromyogram
Clinical narrative: Burning and extreme pain in legs and feet, eventually spread up my body. Lost the ability to walk and use hands. Extreme burning in limbs hands feet and face diagnosed with CIDP
Age: 41.0
Sex: F
Vaccine: RAB
Symptoms: Gait inability, Lumbar puncture, Musculoskeletal disorder, Pain, Pain in extremity
Clinical narrative: Burning and extreme pain in legs and feet, eventually spread up my body. Lost the ability to walk and use hands. Extreme burning in limbs hands feet and face diagnosed with CIDP
Age: 41.0
Sex: F
Vaccine: RAB
Symptoms: Skin burning sensation
Clinical narrative: Burning and extreme pain in legs and feet, eventually spread up my body. Lost the ability to walk and use hands. Extreme burning in limbs hands feet and face diagnosed with CIDP
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Immediate post-injection reaction, Pallor, Syncope
Clinical narrative: Fainted immediately following HPV vaccine. Was sitting on exam table, gurgled, turned pale and was lowered to a lying position and head of table  was raised.  She aroused after approximately 15 seconds and stated she was fine and ready to go.  He father was brought into the room.  She sat up we gave her a cool damp wash cloth for her face and bottle of cold water. Pulse was regular.  She again stated she was fine and ready to go home. Father advised to  call 911 if any issues arise on way home.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Hypotension, Neuropathy peripheral
Clinical narrative: NEUROPATHY 4/2/2023 ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND) ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND) 4/2/2023 ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND) HYPOTENSION 2/17/2023 ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Lung neoplasm malignant, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/1/2023 LUNG CANCER, RIGHT UPPER LOBE
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Cirrhosis alcoholic, Hypotension
Clinical narrative: ACUTE NON ST ELEVATION MI 4/13/2023 ALCOHOLIC CIRRHOSIS HYPOTENSION 4/21/2023 ALCOHOLIC CIRRHOSIS ACUTE NON ST ELEVATION MI 4/13/2023 ALCOHOLIC CIRRHOSIS HYPOTENSION 4/21/2023 ALCOHOLIC CIRRHOSIS
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypercholesterolaemia, Pneumonia, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/24/2023 HYPERCHOLESTEROLEMIA ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/4/2023 HYPERCHOLESTEROLEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/24/2023 PNEUMONIA ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/4/2023 PNEUMONIA
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Febrile neutropenia, Lumbar vertebral fracture, Pathological fracture
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/12/2023 LUMBAR VERTEBRAL PATHOLOGICAL FX, INIT ACUTE RESPIRATORY FAILURE 4/12/2023 NEUTROPENIC FEVER, UNSPECIFIED
Age: 1.25
Sex: M
Vaccine: DTAPIPV
Symptoms: Expired product administered
Clinical narrative: Vaccine given was expired
Age: 0.17
Sex: M
Vaccine: DTPPVHBHPB, PNC15, DTPPVHBHPB, PNC15
Symptoms: Wrong product administered
Clinical narrative: Patient came in the office to receive pneumococcal vaccine and was given Vexelis (DTaP+IPV+Hib+HepB) instead. Once realized, parent and PCP were informed. Patient was then given the correct vaccine, PCV15.
Age: 67.0
Sex: M
Vaccine: UNK
Symptoms: Carditis, Chest pain, Dyspnoea, Nausea, Pericarditis
Clinical narrative: Diagnosed with Pericaditis, inflammation disorder effects on the heart and lungs.
Age: 67.0
Sex: M
Vaccine: UNK
Symptoms: Pneumonitis
Clinical narrative: Diagnosed with Pericaditis, inflammation disorder effects on the heart and lungs.
Age: 18.0
Sex: U
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: Giving expired vaccination; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA660A, expiry date FEB-2023) for prophylaxis.   On 03-JUN-2023, the patient received Menveo. On 03-JUN-2023, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Giving expired vaccination). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 05-JUN-2023 The reporter reported that he or she had an incident as giving expired Menveo vaccine. The patient received a Menveo which was already expired, which led to expired vaccine used.
Age: 47.0
Sex: M
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: Patient received Engerix-B expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 47-year-old male patient who received HBV (Engerix B) (batch number P4DJ5, expiry date 15-DEC-2022) for prophylaxis.   On 31-MAY-2023, the patient received Engerix B. On 31-MAY-2023, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Patient received Engerix-B expired dose). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt date: 31-MAY-2023 A Practice Manager reported about a patient who received expired Engerix-B vaccine. The reporter consented to follow up by email. The patient received an expired dose of Engerix-B vaccine, which led to expired vaccine used.
Age: 41.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Expired product administered, Product administered to patient of inappropriate age
Clinical narrative: two pediatric doses were maladministered as 1 dose to an adult patient; an expired dose of Engerix-B was administered to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a 41-year-old female patient who received HBV (Engerix B pediatric) (expiry date 24-APR-2023) for prophylaxis.   Co-suspect products included HBV (Engerix B pediatric) (expiry date 24-APR-2023) for prophylaxis.   On 17-MAY-2023, the patient received Engerix B pediatric and Engerix B pediatric. On 17-MAY-2023, an unknown time after receiving Engerix B pediatric and Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: two pediatric doses were maladministered as 1 dose to an adult patient) and expired vaccine used (Verbatim: an expired dose of Engerix-B was administered to a patient). The outcome of the adult use of a child product and expired vaccine used were unknown.   Additional Information: GSK receipt date: 31-May-2023 The vaccine dose administered were two pediatric doses with same expiration date but no lot number reported. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via email. An adult patient received two pediatric dose as 1 dose on the same day to complete the volume for 1 adult dose after expiration date, which led to expired vaccine used and adult use of a child product.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Burning sensation, Insomnia, Musculoskeletal pain, Pain
Clinical narrative: Burning hip; Pain/Sore; Cannot sleep; Burning pain in her left buttocks and hip; pain as burning and hurts if cold touches it like someone hit her in the leg; Burning pain in hip; This non-serious case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in October 2022, in left arm, at the same vaccination facility).   In MAR-2023, the patient received the 2nd dose of Shingrix (left arm). On an unknown date, several weeks after receiving Shingrix, the patient experienced burning sensation (Verbatim: Burning hip), pain (Verbatim: Pain/Sore), sleeplessness (Verbatim: Cannot sleep), buttock pain (Verbatim: Burning pain in her left buttocks and hip), leg pain (Verbatim: pain as burning and hurts if cold touches it like someone hit her in the leg) and pain in hip (Verbatim: Burning pain in hip). The outcome of the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip were not resolved.   It was unknown if the reporter considered the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip to be related to Shingrix.     It was unknown if the company considered the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip to be related to Shingrix.   Additional Information: GSK Receipt Date: 31-MAY-2023 The patient self-reported this case. The patient reported the administration of second Shingrix vaccine dose in 2nd week of March 2023 after the couple of weeks she started having a burning pain in the front of her left thigh, and in her left buttocks and hip. The patient described the pain as burning and hurts if cold touches it like someone hit her in the leg. The patient reported this burning pain stayed continuously all day and night; and she could not sleep. During the day it was so sore. Till the time of reporting, the patient had this burning pain. Consent to follow up with healthcare professional was obtained but reporter did not know any of the physician information and could not provide it. The reporter consented to follow up.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Burning hip; Pain/Sore; Cannot sleep; Burning pain in her left buttocks and hip; pain as burning and hurts if cold touches it like someone hit her in the leg; Burning pain in hip; This non-serious case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in October 2022, in left arm, at the same vaccination facility).   In MAR-2023, the patient received the 2nd dose of Shingrix (left arm). On an unknown date, several weeks after receiving Shingrix, the patient experienced burning sensation (Verbatim: Burning hip), pain (Verbatim: Pain/Sore), sleeplessness (Verbatim: Cannot sleep), buttock pain (Verbatim: Burning pain in her left buttocks and hip), leg pain (Verbatim: pain as burning and hurts if cold touches it like someone hit her in the leg) and pain in hip (Verbatim: Burning pain in hip). The outcome of the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip were not resolved.   It was unknown if the reporter considered the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip to be related to Shingrix.     It was unknown if the company considered the burning sensation, pain, sleeplessness, buttock pain, leg pain and pain in hip to be related to Shingrix.   Additional Information: GSK Receipt Date: 31-MAY-2023 The patient self-reported this case. The patient reported the administration of second Shingrix vaccine dose in 2nd week of March 2023 after the couple of weeks she started having a burning pain in the front of her left thigh, and in her left buttocks and hip. The patient described the pain as burning and hurts if cold touches it like someone hit her in the leg. The patient reported this burning pain stayed continuously all day and night; and she could not sleep. During the day it was so sore. Till the time of reporting, the patient had this burning pain. Consent to follow up with healthcare professional was obtained but reporter did not know any of the physician information and could not provide it. The reporter consented to follow up.
Sex: F
Vaccine: HEPAB
Symptoms: Incomplete course of vaccination
Clinical narrative: hadn't received the third dose of the series yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (1st dose received in 18th April 2020) and Twinrix (2nd dose received on an unknown date).   On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: hadn't received the third dose of the series yet). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-JUN-2023 A pharmacist informed that a patient that started the scheme of Twinrix back in April 2020 had not received the third dose of the series yet. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Till the time of reporting, the patient did not receive 3rd dose of Twinrix, which led to incomplete course of vaccination. Details pertains to 1st and 2nd dose of Twinrix in product tab.